Key Drivers
- Margin Recovery
- Positive Cashflow
- Excessive Leverage
AIAI Summary
BKD is now a leveraged asset-ownership and operating-turnaround bet—not merely an occupancy recovery—where sustained occupancy-led EBITDA and free-cash-flow growth must prove sufficient to deleverage its $5.5B debt load; investors should wait for repeatable cash conversion and improving interest coverage before underwriting the upside from owned real estate.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Recovery
- •Positive Cashflow
- •Excessive Leverage
BKD's improving revenue, margins, liquidity, and free cash flow are outweighed by extreme leverage, negative equity, weak interest coverage, and an elevated EV/EBITDA valuation.
Price Behavior
Key Price Behavior Insights:
- •Accelerating decline
- •Support under pressure
- •Reclaim needed
BKD is in a weakening last-month downtrend, with $11.45 support at risk and upside requiring a reclaim of $11.70–$11.80.
Fell from $12.20 to $11.45 over seven sessions
Sentiment & News
Key News Insights:
- •Shares Oversold
- •Institutional Buying
- •Analyst Support
Brookdale's sharp selloff is tempered by positive analyst targets, rising institutional buying, and upcoming investor events, suggesting potential recovery support.
Constructive sentiment and new institutional positions may help stabilize Brookdale shares despite recent weakness
Similar Companies in Healthcare
Other companies in the same sector with AI ratings